The North America sepsis diagnostics market is expected to grow from US$ 279.06 million in 2021 to US$ 513.33 million by 2028; it is estimated to grow at a CAGR of 9.1% from 2021 to 2028.

Sepsis diagnosis requires laboratory skills and proficiency to process the collection and investigation of the clinical sample. Sepsis is a life-threatening illness that needs to be diagnosed and treated at the earliest with the help of skilled healthcare professionals. The lack of experienced professionals is a significant concern in North America. The deficit is due to the declining emigration of healthcare professionals and the lack of proper healthcare infrastructure and medical graduates, which acts as a restraint on the development of the public health system in that region. Such restrictions are expected to hamper the growth of the North America sepsis diagnostics market over the forecast period. Additionally, only 50% of patients with severe sepsis, transported by the emergency medical software (EMS) system, have a paramedic. The lack of trained paramedics affects each phase of patient care in sepsis awareness and screening of patients for the presence of sepsis.

With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the North America sepsis diagnostics market. The North America sepsis diagnostics market is expected to grow at a good CAGR during the forecast period.

North America Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million )

North America Sepsis Diagnostics Market Segmentation

The North America sepsis diagnostics market is segmented based on product, technology, method, test type, pathogen, end user, and country. Based on product, the market is divided into instruments, reagents and assays, blood culture media, and software. The blood culture media segment dominated the North America sepsis diagnostics market in 2021. In terms of technology, the market is categorized into molecular diagnostics, flow cytometry, microfluidics, immunoassay, biomarkers, and microbiology. The microbiology segment dominated the North America sepsis diagnostics market in 2021. Based on method, the market is categorized into automated diagnostics and conventional diagnostics. The conventional diagnostics segment dominated the North America sepsis diagnostics market in 2021. Based on test type, the North America sepsis diagnostics market is categorized into point-of-care tests and laboratory tests. The laboratory tests segment dominated the market in 2021. In terms of pathogen, the North America sepsis diagnostics market is categorized into bacterial sepsis, fungal sepsis, and others. The bacterial sepsis segment dominated the North America sepsis diagnostics market in 2021. Based on end user, the North America sepsis diagnostics market is categorized into hospitals, pathology and reference laboratories, and others. The hospitals segment dominated the North America sepsis diagnostics market in 2021. Based on country, the North America sepsis diagnostics market is segmented into the US, Canada, and Mexico. The US dominated the North America sepsis diagnostics market in 2021.

Key players operating in the North America sepsis diagnostics market include Abbott; F. HOFFMANN-LA ROCHE LTD.; Immunexpress Inc.; BD; Danaher (Beckman Coulter); Luminex Corporation; THERMO FISHER SCIENTIFIC INC.; bioMerieux SA; and T2 Biosystems, Inc. by Altair.

TABLE OF CONTENTS

1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 North America Sepsis Diagnostics Market – By Product
1.3.2 North America Sepsis Diagnostics Market – By Technology
1.3.3 North America Sepsis Diagnostics Market – By Method
1.3.4 North America Sepsis Diagnostics Market – By Test Type
1.3.5 North America Sepsis Diagnostics Market – By Pathogen
1.3.6 North America Sepsis Diagnostics Market – By End User
1.3.7 North America Sepsis Diagnostics Market – By Country
2. Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. North America Sepsis Diagnostics Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America PEST Analysis
4.3 Experts Opinion
5. North America Sepsis Diagnostics Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 High Incidence of Sepsis due to Increasing Nosocomial Infections
5.1.2 Rise in Demand for Rapid Diagnostic Tests Leading to Increasing Product Launches
5.2 Market Restraints
5.2.1 Lack of Skilled Professionals
5.3 Market Opportunities
5.3.1 Increase in Funding and Support for Sepsis Diagnostics Research
5.4 Future Trends
5.4.1 Rising Technological Advancements in Sepsis Diagnosis
5.5 Impact Analysis
6. Sepsis Diagnostics Market– North America Analysis
6.1 North America Sepsis Diagnostics Market Revenue Forecast and Analysis
7. North America Sepsis Diagnostics Market Revenue and Forecasts To 2028– By Product
7.1 Overview
7.2 North America Sepsis Diagnostics Market, By Product, 2021 & 2028 (%)
7.3 Instruments
7.3.1 Overview
7.3.2 Instruments: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
7.4 Reagents and Assays
7.4.1 Overview
7.4.2 Reagents and Assays: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
7.5 Blood Culture Media
7.5.1 Overview
7.5.2 Blood Culture Media: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
7.6 Software
7.6.1 Overview
7.6.2 Software: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
8. North America Sepsis Diagnostics Market Revenue and Forecasts To 2028 – By Technology
8.1 Overview
8.2 North America Sepsis Diagnostics Market Share by Technology – 2021 & 2028 (%)
8.3 Molecular Diagnostics
8.3.1 Overview
8.3.2 Molecular Diagnostics: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.3.2.1 Polymerase Chain Reaction
8.3.2.1.1 Overview
8.3.2.1.2 Polymerase Chain Reaction: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.3.2.2 Peptide Nucleic Acid-Fluorescent in Situ Hybridization
8.3.2.2.1 Overview
8.3.2.2.2 Peptide Nucleic Acid-Fluorescent in Situ Hybridization: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.3.2.3 Syndromic Panel-Based Testing
8.3.2.3.1 Overview
8.3.2.3.2 Syndromic Panel-Based Testing: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.3.2.4 Microarrays
8.3.2.4.1 Overview
8.3.2.4.2 Microarrays: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.4 Flow Cytometry
8.4.1 Overview
8.4.2 Flow Cytometry: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.5 Microfluidics
8.5.1 Overview
8.5.2 Microfluidics: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.6 Immunoassay
8.6.1 Overview
8.6.2 Immunoassay: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.7 Biomarkers
8.7.1 Overview
8.7.2 Biomarkers: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.8 Microbiology
8.8.1 Overview
8.8.2 Microbiology: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
9. North America Sepsis Diagnostics Market Revenue and Forecasts To 2028 – By Method
9.1 Overview
9.2 North America Sepsis Diagnostics Market Share by Method – 2021 & 2028 (%)
9.3 Automated Diagnostics
9.3.1 Overview
9.3.2 Automated Diagnostics: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
9.4 Conventional Diagnostics
9.4.1 Overview
9.4.2 Conventional Diagnostics: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
10. North America Sepsis Diagnostics Market Revenue and Forecasts To 2028 – By Test Type
10.1 Overview
10.2 North America Sepsis Diagnostics Market Share by Test Type – 2021 & 2028 (%)
10.3 Point-of-Care Tests
10.3.1 Overview
10.3.2 Point-of-Care Tests: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
10.4 Laboratory Tests
10.4.1 Overview
10.4.2 Laboratory Tests: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
11. North America Sepsis Diagnostics Market Revenue and Forecasts To 2028 – By Pathogen
11.1 Overview
11.2 North America Sepsis Diagnostics Market Share by Pathogen – 2021 & 2028 (%)
11.3 Bacterial Sepsis
11.3.1 Overview
11.3.2 Bacterial Sepsis: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
11.4 Fungal Sepsis
11.4.1 Overview
11.4.2 Fungal Sepsis: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
11.5 Others
11.5.1 Overview
11.5.2 Others: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
12. North America Sepsis Diagnostics Market – By End User
12.1 Overview
12.2 North America Sepsis Diagnostics Market Share by End User – 2021 & 2028 (%)
12.3 Hospitals
12.3.1 Overview
12.3.2 Hospitals: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
12.4 Pathology and Reference Laboratories
12.4.1 Overview
12.4.2 Pathology and Reference Laboratories: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
12.5 Others
12.5.1 Overview
12.5.2 Others: Sepsis Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
13. North America Sepsis Diagnostics Market – By Country Analysis
13.1 North America: Sepsis Diagnostics Market
13.1.1 Overview
13.1.2 North America: Sepsis Diagnostics Market, by Country, 2021 & 2028 (%)
13.1.2.1 US: Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
13.1.2.1.1 Overview
13.1.2.1.2 US: Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
13.1.2.1.3 US: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
13.1.2.1.4 US: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)
13.1.2.1.4.1 US: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Molecular Diagnostics (US$ Million)
13.1.2.1.5 US: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Method (US$ Million)
13.1.2.1.6 US: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Test Type (US$ Million)
13.1.2.1.7 US: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Pathogen (US$ Million)
13.1.2.1.8 US: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By End User (US$ Million)
13.1.2.2 Canada: Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
13.1.2.2.1 Overview
13.1.2.2.2 Canada: Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
13.1.2.2.3 Canada: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
13.1.2.2.4 Canada: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)
13.1.2.2.4.1 Canada: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Molecular Diagnostics (US$ Million)
13.1.2.2.5 Canada: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Method (US$ Million)
13.1.2.2.6 Canada: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Test Type (US$ Million)
13.1.2.2.7 Canada: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Pathogen (US$ Million)
13.1.2.2.8 Canada: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By End User (US$ Million)
13.1.2.3 Mexico: Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
13.1.2.3.1 Overview
13.1.2.3.2 Mexico: Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
13.1.2.3.3 Mexico: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
13.1.2.3.4 Mexico: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)
13.1.2.3.4.1 Mexico: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Molecular Diagnostics (US$ Million)
13.1.2.3.5 Mexico: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Method (US$ Million)
13.1.2.3.6 Mexico: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Test Type (US$ Million)
13.1.2.3.7 Mexico: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Pathogen (US$ Million)
13.1.2.3.8 Mexico: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By End User (US$ Million)
14. Sepsis Diagnostics Market–Industry Landscape
14.1 Overview
14.2 Growth Strategies in the Sepsis Diagnostics Market (%)
14.3 Organic Developments
14.3.1 Overview
14.4 Inorganic Developments
14.4.1 Overview
15. Company Profiles
15.1 Abbott
15.1.1 Key Facts
15.1.2 Business Description
15.1.3 Products and Services
15.1.4 Financial Overview
15.1.5 SWOT Analysis
15.1.6 Key Developments
15.2 F. HOFFMANN-LA ROCHE LTD.
15.2.1 Key Facts
15.2.2 Business Description
15.2.3 Products and Services
15.2.4 Financial Overview
15.2.5 SWOT Analysis
15.2.6 Key Developments
15.3 Immunexpress Inc.
15.3.1 Key Facts
15.3.2 Business Description
15.3.3 Products and Services
15.3.4 Financial Overview
15.3.5 SWOT Analysis
15.3.6 Key Developments
15.4 BD
15.4.1 Key Facts
15.4.2 Business Description
15.4.3 Products and Services
15.4.4 Financial Overview
15.4.5 SWOT Analysis
15.4.6 Key Developments
15.5 Danaher (Beckman Coulter)
15.5.1 Key Facts
15.5.2 Business Description
15.5.3 Products and Services
15.5.4 Financial Overview
15.5.5 SWOT Analysis
15.5.6 Key Developments
15.6 Luminex Corporation
15.6.1 Key Facts
15.6.2 Business Description
15.6.3 Products and Services
15.6.4 Financial Overview
15.6.5 SWOT Analysis
15.6.6 Key Developments
15.7 THERMO FISHER SCIENTIFIC INC.
15.7.1 Key Facts
15.7.2 Business Description
15.7.3 Products and Services
15.7.4 Financial Overview
15.7.5 SWOT Analysis
15.7.6 Key Developments
15.8 bioMerieux SA
15.8.1 Key Facts
15.8.2 Business Description
15.8.3 Products and Services
15.8.4 Financial Overview
15.8.5 SWOT Analysis
15.8.6 Key Developments
15.9 T2 Biosystems, Inc.
15.9.1 Key Facts
15.9.2 Business Description
15.9.3 Products and Services
15.9.4 Financial Overview
15.9.5 SWOT Analysis
15.9.6 Key Developments
16. Appendix
16.1 About The Insight Partners
16.2 Glossary of Terms

LIST OF TABLES

Table 1.             US Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
Table 2.             US Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)
Table 3.             US: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Molecular Diagnostics (US$ Million)
Table 4.             US: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Method (US$ Million)
Table 5.             US: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Test Type (US$ Million)
Table 6.             US: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Pathogen (US$ Million)
Table 7.             US Sepsis Diagnostics Market Revenue and Forecast to 2028, By End User (US$ Million)
Table 8.             Canada: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
Table 9.             Canada: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)
Table 10.          Canada: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Molecular Diagnostics (US$ Million)
Table 11.          Canada: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Method (US$ Million)
Table 12.          Canada: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Test Type (US$ Million)
Table 13.          Canada: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Pathogen (US$ Million)
Table 14.          Canada Sepsis Diagnostics Market Revenue and Forecast to 2028, By End User (US$ Million)
Table 15.          Mexico Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Product (US$ Million)
Table 16.          Mexico: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)
Table 17.          Mexico: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Molecular Diagnostics (US$ Million)
Table 18.          Mexico: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Method (US$ Million)
Table 19.          Mexico: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Test Type (US$ Million)
Table 20.          Mexico: Sepsis Diagnostics Market Revenue and Forecasts to 2028, By Pathogen (US$ Million)
Table 21.          Mexico Sepsis Diagnostics Market Revenue and Forecast to 2028, By End User (US$ Million)
Table 22.          Organic Developments in the Sepsis Diagnostics Market
Table 23.          Inorganic Developments in the Sepsis Diagnostics Market
Table 24.          Glossary of Terms
 
 

LIST OF FIGURES

Figure 1.           North America Sepsis Diagnostics Market Segmentation
Figure 2.           North America Sepsis Diagnostics Market, By Country
Figure 3.           North America Sepsis Diagnostics Market Overview
Figure 4.           Blood Culture Media Segment Held Largest Share of Type Segment in Sepsis Diagnostics Market
Figure 5.           US is Expected to Show Remarkable Growth During the Forecast Period
Figure 6.           North America: PEST Analysis
Figure 7.           North America Experts Opinion
Figure 8.           North America Sepsis Diagnostics Market: Impact Analysis of Drivers and Restraints
Figure 9.           North America Sepsis Diagnostics Market– Revenue Forecast and Analysis – 2021- 2028
Figure 10.        North America Sepsis Diagnostics Market, by Product, 2021 & 2028 (%)
Figure 11.        North America Instruments: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 12.        North America Reagents and Assays: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 13.        North America Blood Culture Media: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 14.        North America Software: Sepsis Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 15.        North America Sepsis Diagnostics Market Share by Technology – 2021 & 2028 (%)
Figure 16.        North America Molecular Diagnostics: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 17.        North America Polymerase Chain Reaction: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 18.        North America Peptide Nucleic Acid-Fluorescent in Situ Hybridization: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 19.        North America Syndromic Panel-Based Testing: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 20.        North America Microarrays: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 21.        North America Flow Cytometry: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 22.        North America Microfluidics: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 23.        North America Immunoassay: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 24.        North America Biomarkers: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 25.        North America Microbiology: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 26.        North America Sepsis Diagnostics Market Share by Method – 2021 & 2028 (%)
Figure 27.        North America Automated Diagnostics: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 28.        North America Conventional Diagnostics: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 29.        North America Sepsis Diagnostics Market Share by Test Type – 2021 & 2028 (%)
Figure 30.        North America Point-of-Care Tests: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 31.        North America Laboratory Tests: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 32.        North America Sepsis Diagnostics Market Share by Pathogen – 2021 & 2028 (%)
Figure 33.        North America Bacterial Sepsis: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 34.        North America Fungal Sepsis: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 35.        North America Others: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 36.        North America Sepsis Diagnostics Market Share by End User – 2021 & 2028 (%)
Figure 37.        North America Hospitals: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 38.        North America Pathology and Reference Laboratories: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 39.        North America Others: Sepsis Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)
Figure 40.        North America: Sepsis Diagnostics Market, by Key Country – Revenue (2021) (US$ Million)
Figure 41.        North America: Sepsis Diagnostics Market, by Country, 2021 & 2028 (%)
Figure 42.        US: Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 43.        Canada: Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 44.        Mexico: Sepsis Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 45.        Growth Strategies in the Sepsis Diagnostics Market (%)
 
 

● Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the North America sepsis diagnostics market.
● Highlights key business priorities in order to assist companies to realign their business strategies
● The key findings and recommendations highlight crucial progressive industry trends in the North America sepsis diagnostics market, thereby allowing players across the value chain to develop effective long-term strategies
● Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
● Scrutinize in-depth North America market trends and outlook coupled with the factors driving the North America sepsis diagnostics market, as well as those hindering it
● Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

The List of Companies – North America Sepsis Diagnostics Market

● Abbott
● F. HOFFMANN-LA ROCHE LTD.
● Immunexpress Inc.
● BD
● Danaher (Beckman Coulter)
● Luminex Corporation
● THERMO FISHER SCIENTIFIC INC.
● bioMerieux SA
● T2 Biosystems, Inc